DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Schmid P, Cortes J, Pusztai L. et al. KEYNOTE-522 Investigators.
Pembrolizumab for Early Triple-Negative Breast Cancer.
N Engl J Med 2020;
382: 810-821
We do not assume any responsibility for the contents of the web pages of other providers.